[ Price : $8.95]
Public Citizen asks a federal court to order the Trump administration to make public the terms of drug pricing deals it signed wit...[ Price : $8.95]
An Akin legal update says FDAs recent issuance of Warning Letters to four direct-to-consumer testing companies over the use of una...[ Price : $8.95]
FDA cites Nubratori Inc. for multiple manufacturing and contamination-control deficiencies following a December inspection of the ...[ Price : $8.95]
HHS Office of Inspector General issues new guidance clarifying when pharmaceutical manufacturers can sell prescription drugs direc...[ Price : $8.95]
Faced with a legal deadline for a response, FDA denies without comment on the specifics a law firms petition seeking restrictions ...[ Price : $8.95]
The CDRH 2025 annual report says the Center authorized 124 novel medical devices last year, one of the highest numbers of authoriz...[ Price : $8.95]
FDA places clinical holds on two Regenxbio investigational gene therapy programs for ultra-rare pediatric diseases following the i...[ Price : $8.95]
A Ropes & Gray year-end review examines significant changes in FDA and Justice Department enforcement actions pertaining to regula...